About CVS Health Corp
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://cvshealth.com/
Frequently Asked Questions
What is the 52-week range for CVS?
The 52-week high is $110.68 and the 52-week low is $69.51.
What is the P/E ratio for CVS?
The Price to Earnings (P/E) ratio is 22.61.
What is the dividend yield for CVS?
The indicated annual dividend yield is 3.49%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 6.41%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 1.18%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.34.
Analyst Recommendation Trends
Wall Street analyst consensus for CVS over the last few months:
Latest CVS News
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2027 Medicare products with choices designed to support older adults with a wide range of health needs, providing reliable benefits that enable affordability and access to quality care. We are expanding the availability of our Chronic Condition Special Needs Plans, growing our High Value Provider Incentive Program, and continuing to focus on care navigation and support.
Why Is CVS Health (CVS) Reworking Primary Care Around Value Based Care?
CVS Health (NYSE:CVS) is expanding its primary care approach by integrating value-based care across its health system. The company intends to connect health plans, provider groups, clinics, and pharmacies under a single patient-centered care model. Management is targeting shared accountability for outcomes that include social determinants of health alongside traditional clinical metrics. This push to embed value-based care across CVS Health's operations reshapes how the group manages care,...
UnitedHealth and Humana cutting Medicare Advantage plans in 2027
CVS Health's Aetna and Centene are also shrinking their Medicare Advantage offerings as insurers pull back from less profitable markets
CVS Health: After 30 Years, a Hepatitis C Treatment That Finally Worked
NORTHAMPTON, MA / ACCESS Newswire / October 2, 2026 / Originally published on Company NewsroomFor more than 30 years, Mary lived with hepatitis C, uncertain whether she would ever be free of the disease. Then earlier this year, she received the news she had been waiting decades to hear.
How Much Downside Is Left In CVS Health Stock?
CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway.
Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.
Why McKesson Stock Soared More Than 5% Higher Today
The company extended its existing partnership with a major pharmacy chain.
Why McKesson (MCK) Stock Is Trading Up Today
Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 4.4% in the afternoon session after the company reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.
Cardinal Health rises on extended CVS distribution deal
Investing.com -- Cardinal Health Inc (NYSE:CAH) shares rose 3.7% in Thursday trading after the company announced an extension of its drug distribution agreement with CVS Health through June 2032.
Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks
Markets are back to obsessing over central bank signals, supply routes and growth downgrades, and that mix is shaking up how investors look at reliable income. When credit feels tighter and headlines keep flagging disruption risks, steady dividend cheques from global healthcare stocks can suddenly look more interesting. This piece walks through three healthcare dividend payers from our screener that appear closely exposed to the latest macro news and explains why their stories might matter to...
Ask a CVS Pharmacist: Your Top Flu Shot Questions, Answered
WOONSOCKET, RI / ACCESS Newswire / October 1, 2026 / Originally published on Company NewsroomCVS Pharmacy pharmacists answer common flu shot questions, including whether flu, COVID-19 and other recommended vaccines can be given during the same visit.Flu season is approaching, and September and October are generally ideal times for most people to get vaccinated.
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032
Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.
Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.
Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032
Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal
CVS Health declares quarterly dividend
CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 2, 2026, to holders of record on October 22, 2026.
Cigna Investor Day Spotlights Specialty Drugs
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?
Danaher's Biotechnology segment posts 4% sales growth, but tough comparisons and shipment timing could test its momentum.
Hunger Action Month: Supporting Healthier Communities Through Better Access to Nutritious Food
WOONSOCKET, RI / ACCESS Newswire / September 30, 2026 / Originally published on Company NewsroomMillions of people across the United States face food insecurity, making it harder to stay healthy, manage chronic conditions and focus on everyday life. During Hunger Action Month, is highlighting the organizations working every day to ensure individuals and families can access the nutritious meals they need.
Chicago multifamily developer acquires seven-story Gold Coast building for residential conversion
Alex Milanoski of Newstreet Properties, 1165 North Clark Street in Chicago and Daniel Sobelman of CRE Bridge Capital (LinkedIn, Newstreet Properties, CRE Bridge Capital)A Chicago-based multifamily developer acquired a seven-story office building for $6.8 million last week, with plans to convert it into an 80-unit multifamily complex in the Gold Coast neighborhood, The Real Deal learned. Newstreet, recently rebranded from Initium Development, purchased the property at 1165 North Clark Street, anc
What Are UNH Stock Investors Betting On?
UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.
Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
Coverbase Adds Third-Party Risk Veterans as Enterprise Adoption Accelerates
Brian Shaw and Constantine Malaxos join as enterprise customers expand across financial services, healthcare, and technologySAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Coverbase, AI engineered for third-party risk management (TPRM), today announced that Brian Shaw has joined as GTM Lead and Constantine Malaxos as Head of Alliances. Both bring decades of experience building and selling third-party risk technology to large enterprises. In less than a year since closing its Series A, Coverbas
Value-Based Care Is Hard, but It's Worth Getting Right
Sree Chaguturu, MD, President of Health Care Delivery, WOONSOCKET, RI / ACCESS Newswire / September 29, 2026 / Originally published on Company NewsroomKey points * Value-based primary care has stalled in many places not because the model is wrong, but because too many have approached it as a contracting exercise, signing the risk deal and documenting patients' clinical conditions, instead of the harder work of integrating care around the patient. * Scaling it takes connecting the whole system ar
CVS Health (CVS) Falls More Steeply Than Broader Market: What Investors Need to Know
The latest trading day saw CVS Health (CVS) settling at $87.85, representing a -1.44% change from its previous close.
CVS Health Is Making a Difference in Local Communities, One Classroom at a Time
NORTHAMPTON, MA / ACCESS Newswire / September 28, 2026 / Originally published on Company NewsroomWhen students and teachers return to the classroom, having the right supplies can make a meaningful difference. This year, and Aetna teamed up with community organizations and some of our sports partners - The Washington Spirit, Kansas City Current and the Boston Red Sox - to help students and their families start the school year with the resources, confidence, and support they need to thrive.
CVS Health (CVS) Settles Website Tracking Privacy Case For $20.5 Million
CVS Health (NYSE:CVS) and ad tech firm Criteo agreed to a US$20.5 million settlement resolving website tracking litigation over user data. The suit alleged CVS Health shared personal and protected health information with third parties through online tracking tools without user consent. The agreement covers claims that Criteo received sensitive CVS website visitor data that was allegedly used for targeted advertising purposes. This US$20.5 million privacy settlement over CVS website tracking...
CVS Health (CVS) Reclaims Its 200 Day EMA, Is The Stock Still A Bargain?
Why CVS Health Stock Is Back On Traders’ Screens CVS Health (CVS) has jumped back into focus after a 4.8% move on September 25 pushed the share price to $89.13 and back above its 200 day EMA. That single session pulled the stock higher even as the broader daily trend still points lower. This has given short term traders fresh technical signals, while longer term investors are assessing whether this latest bounce changes the story. Set against that sudden spike, CVS Health has had a mixed run,...
‘Those Billionaires and Rich Execs Have No Clue’: Mark Cuban Says If Healthcare Is Too Expensive, Cash ‘May Be Cheaper Than Your Out-of-Pocket’
Billionaire Mark Cuban says that, in some cases, it might actually be cheaper to pay cash for certain treatments and prescriptions.
Walmart hit by retail theft, gift card scam
Here’s how to protect yourself and what to watch out for.
CVS Health Stock Still Looks Good Even If Health Cost Woes Materialize
CVS Health Corporation remains fairly attractive, rated a soft Buy due to improved profitability and relative valuation. Read more on CVS stock here.
CVS may owe you money. How to claim it in Arizona
CVS customers in Arizona may be owed money from a lawsuit settlement involving the company. Here's what you need to know.
CVS is a 'decent stock to tuck away,' says F.L. Putnam's Ellen Hazen
F.L. Putnam's Chief Market Strategist Ellen Hazen joins 'Power Lunch' to talk what stocks she likes in the current market.
Mark Cuban Says He’s ‘All for Universal Care’ But Warns It Won’t ‘Automagically Work,’ and the ‘Best First Step’ Is This Warren-Hawley Bill
Cuban believes in Medicare for All, but thinks people need to temper their expectations. He thinks a recently introduced bill is most consumers' best shot for now.
CVS Health Strengthens Energy Resilience To Support Patient Care
NORTHAMPTON, MA / ACCESS Newswire / September 25, 2026 / Originally published on Company NewsroomThe demand for reliable energy continues to grow, and for , dependable operations are essential to serving millions of patients and customers across the country. That's why we're expanding our use of renewable electricity and investing in energy solutions that help reduce emissions, strengthen business resilience and support uninterrupted care.
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
‘That’s Immediate Cash in the Bank’: Billionaire Mark Cuban Says the Quickest Way for a Company to Raise Money Is to Change Its PBM
Mark Cuban offers an unconventional way for employers to raise funding if they need it: Change your PBM.
What Should CVS Stock Investors Be Watching Now?
If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Aetna Expands Bundled Oncology Prior Authorizations, Easing Provider Burden and Accelerating Member Access to Care
* Oncology bundling to support all eligible Medicaid members for all cancer types * Full roll-out across all Aetna businesses in 2027Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 24, 2026 / Aetna®, a ® company (NYSE:CVS), is expanding prior authorization bundles across all cancer types for members in eligible1 Medicaid states as of September 1, with plans to expand across all lines of business in 2027. This expansion builds on the success of the initial rol
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vet group CVS says portrayal of industry ‘disappointing’ amid reforms
The company also announced its first acquisition in the UK days after the conclusion of the Competition and Markets Authority probe.
CVS Group H2 Earnings Call Highlights
CVS Group (LON:CVSG) reported higher revenue, adjusted EBITDA and adjusted earnings per share for the year ended June 30, 2026, while highlighting softer U.K. companion-animal demand late in the year and continued expansion in Australia. Revenue rose 5.9% to £712.8 million, supported by acquisition
Did UnitedHealth Name The Fix Before Its Stock Ran?
UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.
As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide
Following the Tennessee Department of Health's recent confirmation of nine measles cases in the state, CVS Health® (NYSE:CVS) is reminding Tennesseans that the measles-mumps-rubella (MMR) vaccine is available at CVS Pharmacy® and MinuteClinic® locations statewide for eligible patients.
CVS Health Launches National "Wear Your HeART" Bandage Art Contest
Four winning designs will be featured on limited-edition CVS brand bandages for sale in 2027Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 23, 2026 / ® (NYSE:CVS) recently announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health.The contest offers artists, students, families and community grou
Here’s What Strengthened CVS Health (CVS) in Q2
Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for “Global Equity Strategy”. The letter can be downloaded here. Global markets delivered strong gains during the quarter, supported by an AI-driven earnings rally despite elevated interest rates, inflation concerns, and geopolitical uncertainty. Polaris Global Equity Composite (net of fees) returned 13.26% […]
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields
Analysts review high-yield healthcare stocks CVS, Viatris and Medtronic, citing ratings, price targets, dividend yields and recent company news.
CVS Health (CVS) Stock May Be Undervalued Despite Oncology Authorization Expansion
CVS Health has delivered a 36.9% share price gain over the past three years, even after a recent pullback. This puts fresh focus on whether that climb still lines up with what the business earns. With earnings in the spotlight and the stock giving back some ground in recent weeks, the key issue for you is whether today's valuation is properly grounded in its profit power. The 36.9% return over three years raises the question of how much of that move reflects lasting earnings strength versus...
Can UNH Stock Keep Growing Earnings While Its Sales Stall?
UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.
CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?
CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.
'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive
https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7
Guggenheim Boosts Eli Lilly Price Target Amid Strong Weight Loss Drug Demand
Key Stats for Eli Lilly StockPrice change for Eli Lilly stock in last 6 months: 27%$LLY Stock Price as of Sep. 21: $1,16552-Week High: $1,292$LLY Stock Price Target: $1,325What Happened?Eli Lilly (LLY) stock is drawing fresh attention today after Guggenheim raised its price target to $1,284 from $1,273 and maintained a Buy rating.
Haleon Turns to Weight-Loss Drug Users for its Next U.S. Growth Opportunity
Haleon plc (NYSE:HLN) is finding a new growth opportunity in the expanding U.S. population using GLP-1 weight-loss drugs such as Wegovy and Zepbound. According to Reuters, the company has been placing products that can address GLP-1-related side effects in both its normal store locations and dedicated GLP-1 sections at CVS. That strategy has produced an […]
CVS Health’s Yield Touched 3% as the Stock Slid. Is the Payout a Bargain or a Warning?
Key Stats for CVS Health StockCurrent Price: $88. 84Target Price (Mid): ~$130Street Target: ~$116Potential Total Return: ~47%Annualized IRR: ~9% / yearWhat Happened?CVS Health (CVS) slid to a $88.
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
CVS Health (CVS) concluded the recent trading session at $87.6, signifying a -1.4% move from its prior day's close.
Here's What Might Affect CVS Health's 2026 Financial Outlook
CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.
VIO Med Spa Enters South Carolina with Three-Unit Agreement in Charleston
VIO Med Spa, a nationally recognized, physician-guided medical spa franchise specializing in advanced, non-invasive aesthetic and wellness treatments, has signed a three-unit development agreement to enter South Carolina for the first time, bringing the brand to the greater Charleston area. The first location is expected to open in 2027, with site selection currently underway.
Judge approves CVS unit Omnicare’s bankruptcy plan
The plan should make all Omnicare creditors, including the Department of Justice, whole.
Top 3 Health Care Stocks That May Rocket Higher In September
CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
A drugmaker is gaining from the side effects of weight-loss drugs
The consumer health company’s GLP-1 shelf strategy at CVS is paying off, and bigger retailers could follow.
Health Insurance Providers Stocks Q2 Earnings Review: CVS Health (NYSE:CVS) Shines
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).
Ascension sells ownership in Arizona Medicaid plan to Aetna
The sale lets Ascension shed insurance risk while Aetna gains a stake in a profitable plan serving high-margin dual-eligible members.
CVS division completes Chapter 11 bankruptcy liquidation
A piece of the company is winding down its operations under CVS Health.
CVS Health Redevelops Soccer Pitch Alongside Seattle Reign FC and the RAVE Foundation
Originally published on Company NewsroomThe new mini-pitch brings safe access to play to Orchards Elementary School in Vancouver, WA, as part of 's multi-year field revitalization commitmentNORTHAMPTON, MA AND WOONSOCKET, RI / ACCESS Newswire / September 18, 2026 / ® (NYSE:CVS) announced it has redeveloped a mini soccer pitch in collaboration with Seattle Reign FC and the club's charitable arm, the RAVE Foundation. The mini-pitch, which is located at Orchards Elementary in Vancouver, WA, is now
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?
CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.
Can Kroger Keep Its Earnings Promise With Sales This Weak?
Kroger (KR) has cut its 2026 same-store sales outlook and kept its 2026 profit outlook. If you own the stock, the easy comfort is that earnings held. The risk sits inside that comfort. The cost savings holding up profit are the same savings management plans to spend on lower shelf prices, and the stock is down 15% over the past six months.
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
When "Something's Off" Isn't Something To Ignore: Understanding PMOS
Joanne Armstrong, Chief Medical Officer and Vice President, Women's Health, WOONSOCKET, RI / ACCESS Newswire / September 17, 2026 / Originally published on Company NewsroomDespite affecting millions of women, Polyendocrine Metabolic Ovarian Syndrome, formerly known as Polycystic Ovary Syndrome (PCOS), remains one of the most misunderstood conditions in women's health. PMOS also illustrates a broader challenge: when a condition is defined primarily by its reproductive features, its effects across
CVS Health's Aetna Reduces Administrative Tasks For Cancer Care
CVS unit Aetna expands prior authorization bundles to accelerate cancer care and reduce administrative burdens for healthcare providers.
3 Health Care Stocks Built For Higher Rates
When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...
CVS Health Unit Aetna Announces Expansion Of Prior Authorization Bundles Across All Cancer Types For Members In Eligible Medicaid States As Of September 1, With Plans To Expand Across All Lines Of Business In 2027
This expansion builds on the success of the initial roll-out, with almost 25% of eligible members receiving a bundled prior authorization, assuring their services have been approved in advance to accelerate their access
How Tech Leaders Are Navigating AI’s ROI Problem
At the WSJ Leadership Institute's Technology Council Summit, technology executives from McKinsey, FedEx and CVS Health discuss how they are navigating the rising costs of generative AI and finding real business value.
The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.
Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.
CVS Trading Well Below Wall Street Targets After Month’s Softening Creates Opening
CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could turn this setup into a trap.
Thank You! CVS Health Celebrates Tabor Village Affordable Housing Groundbreaking in Dallas, Texas
NORTHAMPTON, MA / ACCESS Newswire / September 16, 2026 / Last month, proudly celebrated the Groundbreaking of Tabor Village in Dallas alongside colleagues, local leaders, community organizations, and development and financing collaborators. This milestone marked the start of construction on a 229-unit mixed-income community for older adults, including 206 affordable homes for residents age 55+ earning up to 50% and 60% of Area Median Income and 23 market-rate homes.
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
CVS Health (CVS) concluded the recent trading session at $94.43, signifying a -1.17% move from its prior day's close.
What Does CVS Health (CVS) Updated COVID Vaccine Rollout Mean For Patients?
CVS Health (NYSE:CVS) announced the rollout of updated 2026 to 2027 COVID-19 vaccines across CVS Pharmacy and MinuteClinic locations. The new vaccines are positioned for broad availability through CVS Health’s nationwide network of retail pharmacies and in store clinics. CVS Health highlighted the vaccines as part of its role in supporting ongoing COVID-19 management and wider public health efforts. This fresh 2026 to 2027 COVID-19 vaccine rollout at CVS Health sits against a wider backdrop...
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth
CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.
Thank You! CVS Health Awards Grant to Windy City Harvest During Grace Manor Community Event in Chicago, Illinois
NORTHAMPTON, MA / ACCESS Newswire / September 15, 2026 / Last month, , Aetna Better Health of Illinois, Oak Street Health and community leaders gathered at Grace Manor in Chicago's North Lawndale neighborhood to host a resident-focused resource fair designed to support health, wellness, education and economic opportunity. The event brought together residents, local leaders and community organizations for a day of health services, resource connections and family-friendly activities.
CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions
NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio
Why CVS Health’s Tech Chief Says He's 'Allergic' to the 'Chief AI Officer' Title
Tilak Mandadi, chief experience and technology officer at CVS Health, criticized the growing trend of appointing "Chief AI Officers," and explains what leaders should be focusing on instead.
How CVS Health Uses AI Simulations to Accelerate Research
At the WSJ Leadership Institute's Tech Council Summit, CVS Health’s Sri Narasimhan breaks down how AI simulations are disrupting traditional market research.
CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?
The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.
How CVS Health is Recreating Human Behavior
Joon Sung Park, chief executive of AI startup Simile, and Tilak Mandadi and Sri Narasimhan of CVS Health discuss the practical applications, accuracy and enterprise potential of AI-driven human behavior simulations.
Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?
UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.
Should You Buy CVS Stock on the Dip?
CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.
Wizard Wellness Completes National Mass Retail Rollout in Four Weeks Closing $1 Million Funding Round
SAN FRANCISCO, September 14, 2026--Wizard Wellness, the brand treating allergy care with the same rigor and sensory appeal as skincare, today completed its national mass retail distribution across all three of the country’s largest mass retailers within four weeks, reaching more than 4,000 doors. The retail play comes after a significant funding round of over $1 million from new investors Pave Health Ventures and Vanquish Equity, joined by existing backers True Beauty Ventures and Barrier Island
Promino Holds Rejuvenate Muscle Health(TM) U.S. Retail Pricing as Whey Protein Costs Remain at Record Levels
WPC80 whey pricing has increased more than fivefold since 2023, reaching approximately US$14.50/lb in 2026Rejuvenate remains US$24.99 for 14 servings and US$39.99 for 30 servings at U.S. retail — as much as 40% lower per serving than a current leading 2-lb whey benchmarkPublished human research supports the ability of a low-dose leucine-rich essential amino acid formulation to stimulate muscle protein synthesis comparably to 20g of whey proteinRejuvenate is available in approximately 6,800 CVS..
Walgreens retreats as CVS quietly takes over suburban pharmacies
CVS is picking up the overflow as Walgreens closes 1,200 stores and goes private.
The biggest threat to your retirement is based on a myth — it could rip through your nest egg and even ruin your health
Older workers are forced to battle assumptions that they are slow learners and are baffled by technology.
Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food
President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Morris and other companies, agreeing to divest if confirmed.
Should You Buy Elevance Health Stock For The Margin It Lost?
Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?
CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S.
Appointments can be scheduled through the app or CVS.com and walk-ins are acceptedOriginally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 10, 2026 / ® (NYSE:CVS) announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans.
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom
CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of
CVS Health: Buy The Pullback Before Earnings Power Ramps Up
CVS Health looks undervalued at 12x forward P/E as revenue and operating income rebound; learn key catalysts, risks, and why a Buy may fitâread now.
CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
CVS Health Corporation (CVS) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 9:30 AM EDTCompany ParticipantsBrian Newman - Executive VP...
Why Is UNH Stock Trading At A Premium With The Slowest Growth?
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.
CVS Health Marks 20 Years of Free Community Health Screening Program As New Survey Reveals Many U.S. Adults Still Face Barriers to Preventive Health Screenings
Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 9, 2026 / New survey findings commissioned by ® (NYSE:CVS) reveal that many Americans face persistent barriers accessing preventive health screenings. Nearly one in four adults have delayed speaking with a health professional about health concerns because of barriers related to access, cost or availability, and one-third were unaware that community screening programs exist.
Mitch Gould Brings Decades of Retail Sales Experience to ECRM
Nutritional Products International CEO has sold millions of dollars in products to Walgreens, CVS, Walmart, Target, GNC, Vitamin Shoppe and other major retailersBOCA RATON, FL / ACCESS Newswire / September 9, 2026 / Mitch Gould, founder and CEO of Nutritional Products International (NPI), will bring decades of retail sales experience to the ECRM Vitamin, Weight Management & Sports Nutrition Session, taking place Sept. 14-17 in Palm Beach Gardens, Florida.
Wall Street Loves CVS Health Stock Right Now. Should You?
The stock is down about 13% from its 52-week high.
2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
What Women Want From Weight Management Support, and Why It Matters
by Raj Patel, Joanne Armstrong, and Michelle GourdineOriginally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 8, 2026 / Historically, weight management has been framed as a matter of diet, exercise and willpower. But for many women, the experience is far more complex.
The Shingles Vaccine Is $0 at the Pharmacy. Get the Same Shot at Your Doctor’s Office and the Front Desk Asks for $200 Per Dose.
The shingles vaccine costs nothing under Medicare Part D, yet thousands of beneficiaries walk out of their doctor's office owing hundreds of dollars for the exact same shot. The billing system has a gap, and most patients have no idea it exists until they're already holding the receipt.
Here's How CVS Is Focusing on Aetna's Profitability Turnaround
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
CVS Health (CVS) Stock Looks Below Fair Value But Mixed After 65% Return
CVS Health stock has delivered a strong 64.8% return over the past three years, and the current valuation picture is not a clear bargain or a clear stretch. Recent gains sit alongside a mixed value score and fresh headlines around its health insurance and compliance record, which give investors a few moving parts to weigh. The 64.8% three year return highlights how much value the market has already credited to CVS Health, so fresh buyers now have to judge whether that past performance still...
CVS Health (CVS) Makes Updated 2026 2027 COVID 19 Vaccines Available Nationwide
CVS Health (NYSE:CVS) announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic locations across the United States. The company is offering the new vaccines nationwide, with appointments and walk-in options across its retail and clinic network. CVS Health is integrating COVID-19 shots with other vaccinations, aiming to streamline access to multiple immunizations in a single visit. This kind of broad vaccine rollout highlights how large pharmacy...
Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum
A caller on the September 2 episode of Mad Money noted that CVS Health Corporation (NYSE:CVS) is up 21% this year, sports a 3% dividend, and trades at a 28 valuation compared to its 54 average. Pointing to raised guidance, higher price targets, and a massive capital plan, they asked if it makes sense to […]
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey
* Diagnosed with primary immunodeficiency (PI) as an infant, Nick Stacken has spent decades pursuing his passions, including competing in Special Olympics. * Immunoglobulin (Ig) Therapy is often key to PI care, but ongoing support from pharmacists, nurses and caregivers can help patients build confidence and support their long-term health and personal goals.
Is CVS Health Outperforming the Nasdaq?
CVS Health has outperformed the broader market over the past year, while analysts remain highly bullish on its future prospects.
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 23.2% over the past six months, topping the S&P 500 by 11.5 percentage points.
Life Insurance Premium Growth Fuels Q2 Gains For U.S. Life Insurers
Sector-wide direct premiums and considerations of $268.92B in Q2 represented a 2.0% increase YoY as the sector bounced back from a modest retreat in Q1. Read more here.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-05-31 | Newman Brian | -2,478 | $90.98 | $225,448 |
| 2026-05-31 | Compton-Phillips Amy | -7,618 | $90.98 | $693,086 |
| 2026-05-21 | AGUIRRE FERNANDO | -1,563 | $93.501 | $146,142 |
| 2026-05-21 | ROBBINS LARRY | -378,000 | $93.311 | $35,271,558 |
| 2026-05-21 | ROBBINS LARRY | -370,462 | $93.4482 | $34,619,007 |
| 2026-05-20 | AGUIRRE FERNANDO | -30,437 | $93.775 | $2,854,230 |
| 2026-05-20 | ROBBINS LARRY | -800 | $96.2819 | $77,026 |
| 2026-05-20 | ROBBINS LARRY | -66,881 | $95.6655 | $6,398,204 |
| 2026-05-20 | ROBBINS LARRY | -152,691 | $94.8061 | $14,476,038 |
| 2026-05-20 | ROBBINS LARRY | -797,628 | $93.4766 | $74,559,554 |
| 2026-05-19 | ROBBINS LARRY | -151 | $95.18 | $14,372 |
| 2026-05-19 | ROBBINS LARRY | -1,983,387 | $94.448 | $187,326,935 |
| 2026-05-14 | Finucane Anne A. | +1,544 | $97.15 | $150,000 |
| 2026-05-14 | SANSONE GUY P | +1,447 | $97.15 | $140,576 |
| 2026-05-14 | DECOUDREAUX ALECIA A | +1,448 | $97.15 | $140,673 |
| 2026-05-14 | BROWN C DAVID II | +1,544 | $97.15 | $150,000 |
| 2026-05-14 | Balser Jeffrey R. | +2,058 | $97.15 | $199,935 |
| 2026-05-14 | Shulman Douglas H. | +1,448 | $97.15 | $140,673 |
| 2026-05-14 | Norwalk Leslie V | +1,447 | $97.15 | $140,576 |
| 2026-05-14 | Mahoney Michael F | +1,737 | $97.15 | $168,750 |
| 2026-05-14 | Gallina John E | +1,448 | $97.15 | $140,673 |
| 2026-05-14 | KIRBY J SCOTT | +1,447 | $97.15 | $140,576 |
| 2026-05-14 | ROBBINS LARRY | +1,930 | $97.15 | $187,500 |
| 2026-05-14 | AGUIRRE FERNANDO | +1,563 | $97.15 | $151,845 |
| 2026-05-08 | Mandadi Tilak | -69,551 | $89.58 | $6,230,379 |
| 2026-04-01 | Shah Prem S | -1,484 | $72.49 | $107,575 |
| 2026-04-01 | Mandadi Tilak | -3,634 | $72.49 | $263,429 |
| 2026-04-01 | Clark James David | -3,262 | $72.49 | $236,462 |
| 2026-04-01 | CAPOZZI HEIDI B | -1,334 | $72.49 | $96,702 |
| 2026-04-01 | Khichi Samrat S. | -3,541 | $72.49 | $256,687 |
| 2026-04-01 | Joyner J. David | -8,029 | $72.49 | $582,022 |
| 2026-04-01 | Nelson Steven H | -2,432 | $72.49 | $176,296 |
| 2026-03-31 | Shah Prem S | +161,676 | $71.82 | $11,611,570 |
| 2026-03-31 | Shah Prem S | +25,062 | $71.82 | $1,799,953 |
| 2026-03-31 | Mandadi Tilak | +143,712 | $71.82 | $10,321,396 |
| 2026-03-31 | Mandadi Tilak | +22,277 | $71.82 | $1,599,934 |
| 2026-03-31 | Newman Brian | +125,748 | $71.82 | $9,031,221 |
| 2026-03-31 | Newman Brian | +19,493 | $71.82 | $1,399,987 |
| 2026-03-31 | Clark James David | +11,976 | $71.82 | $860,116 |
| 2026-03-31 | Clark James David | +11,138 | $71.82 | $799,931 |
| 2026-03-31 | Compton-Phillips Amy | +35,928 | $71.82 | $2,580,349 |
| 2026-03-31 | Compton-Phillips Amy | +5,569 | $71.82 | $399,966 |
| 2026-03-31 | CAPOZZI HEIDI B | +64,670 | $71.82 | $4,644,599 |
| 2026-03-31 | CAPOZZI HEIDI B | +10,025 | $71.82 | $719,995 |
| 2026-03-31 | Khichi Samrat S. | +80,838 | $71.82 | $5,805,785 |
| 2026-03-31 | Khichi Samrat S. | +12,531 | $71.82 | $899,976 |
| 2026-03-31 | Joyner J. David | +86,326 | $71.82 | $6,199,933 |
| 2026-03-31 | Nelson Steven H | +143,712 | $71.82 | $10,321,396 |
| 2026-03-31 | Nelson Steven H | +22,277 | $71.82 | $1,599,934 |
| 2026-03-19 | Gallina John E | +582 | $71.86 | $41,823 |
| 2026-02-28 | Khichi Samrat S. | -7,886 | $79.6 | $627,726 |
| 2026-02-28 | Joyner J. David | -1,944 | $79.9 | $155,326 |
| 2026-01-01 | Shah Prem S | -247 | $80.13 | $19,792 |
| 2025-12-01 | Clark James David | -220 | $79.1 | $17,402 |
| 2025-11-30 | Mandadi Tilak | -6,575 | $80.36 | $528,367 |
| 2025-11-30 | CAPOZZI HEIDI B | -9,470 | $80.36 | $761,009 |
| 2025-11-30 | FARAH ROGER N | -9,748 | $80.36 | $783,349 |
| 2025-11-20 | Balser Jeffrey R. | +1,775 | $76.04 | $134,971 |
| 2025-11-20 | Shulman Douglas H. | +1,652 | $76.04 | $125,618 |
| 2025-11-20 | Norwalk Leslie V | +1,652 | $76.04 | $125,618 |
| 2025-11-20 | Mahoney Michael F | +2,022 | $76.04 | $153,753 |
| 2025-11-20 | Finucane Anne A. | +1,775 | $76.04 | $134,971 |
| 2025-11-20 | Finucane Anne A. | +591 | $76.04 | $44,940 |
| 2025-11-20 | SANSONE GUY P | +1,652 | $76.04 | $125,618 |
| 2025-11-20 | KIRBY J SCOTT | +1,652 | $76.04 | $125,618 |
| 2025-11-20 | DECOUDREAUX ALECIA A | +1,652 | $76.04 | $125,618 |
| 2025-11-20 | ROBBINS LARRY | +2,203 | $76.04 | $167,516 |
| 2025-11-20 | AGUIRRE FERNANDO | +1,800 | $76.04 | $136,872 |
| 2025-11-20 | BROWN C DAVID II | +1,775 | $76.04 | $134,971 |